Frontage Holdings Corporation (HKG:1521)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.120
+0.040 (3.70%)
Mar 10, 2026, 3:35 PM HKT
7.69%
Market Cap 2.19B
Revenue (ttm) 1.99B
Net Income (ttm) 30.10M
Shares Out 2.03B
EPS (ttm) 0.01
PE Ratio 72.68
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 62,000
Average Volume 104,600
Open 1.080
Previous Close 1.080
Day's Range 1.080 - 1.130
52-Week Range 0.880 - 1.870
Beta 0.33
RSI 50.98
Earnings Date Mar 27, 2026

About Frontage Holdings

Frontage Holdings Corporation, a contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies. It offers drug discovery services comprising medicinal chemistry, pharmacology, and efficacy, as well as absorption, distribution, metabolism, and excretion (ADME) screening. The company also provides drug metabolism and pharmacokinetics (DMPK); safety and toxicology; early phase clinical services; and bioequivalence and related services, such as pharmacology, medical writing, an... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2018
Employees 1,540
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1521
Full Company Profile

Financial Performance

In 2024, Frontage Holdings's revenue was $254.91 million, a decrease of -1.90% compared to the previous year's $259.86 million. Earnings were $791,000, a decrease of -92.68%.

Financial numbers in USD Financial Statements

News

There is no news available yet.